TEVA PHARMACEUTICALS USA, INC. Federal Contracts — Government Award History
Total (All Time)$205M
Latest FY$14M
Primary AgencyDepartment of Defense
TEVA PHARMACEUTICALS USA, INC. has received $205M in total federal contract awards
across 6 fiscal year(s). ▼ 66.0% vs FY2025 Peak year was FY2021 ($40M).
Primary awarding agency: Department of Defense.
Data covers largest contracts by award amount. Source: USASpending.gov (FPDS).
Awards by Fiscal Year
| Year | Spending | Total | Contracts | Top Agency |
|---|---|---|---|---|
| FY2026 | $13.7M | 11건 | Department of Defense | |
| FY2025 | $40.2M | 61건 | Department of Defense | |
| FY2024 | $38.5M | 75건 | Department of Defense | |
| FY2023 | $36.1M | 77건 | Department of Defense | |
| FY2022 | $35.6M | 92건 | Department of Defense | |
| FY2021 | $40.5M | 107건 | Department of Defense |
Notable Contracts
| Date | Agency | Amount | Description |
|---|---|---|---|
| 2025-01-28 | Department of Defense | $5.3M | 8511147946!ADENOVIRUS TYPE 4 A |
| 2026-02-17 | Department of Defense | $4.0M | 8511918533!ADENOVIRUS TYPE 4 A |
| 2026-01-13 | Department of Defense | $4.0M | 8511856699!ADENOVIRUS TYPE 4 A |
| 2024-11-14 | Department of Defense | $3.2M | 8511009796!ADENOVIRUS TYPE 4 A |
| 2023-12-14 | Department of Defense | $2.4M | 8510325537!ADENOVIRUS TYPE 4 A |
| 2025-12-01 | Department of Defense | $2.0M | 8511784063!ADENOVIRUS TYPE 4 A |
| 2024-04-09 | Department of Defense | $1.6M | 8510559015!ADENOVIRUS TYPE 4 A |
| 2023-12-14 | Department of Defense | $1.5M | 8510325475!ADENOVIRUS TYPE 4 A |
| 2024-07-19 | Department of Defense | $1.4M | 8510766857!ADENOVIRUS TYPE 4 A |
| 2024-06-13 | Department of Defense | $1.4M | 8510688482!ADENOVIRUS TYPE 4 A |
| 2024-05-15 | Department of Defense | $1.4M | 8510634433!ADENOVIRUS TYPE 4 A |
| 2025-12-01 | Department of Defense | $1.3M | 8511784064!ADENOVIRUS TYPE 4 A |
| 2024-09-18 | Department of Defense | $1.3M | 8510902080!ADENOVIRUS TYPE 4 A |
| 2024-01-25 | Department of Defense | $1.3M | 8510401601!ADENOVIRUS TYPE 4 A |
| 2025-08-12 | Department of Defense | $1.2M | 8511565495!ADENOVIRUS TYPE 4 A |
| 2025-01-28 | Department of Defense | $1.2M | 8511148052!ADENOVIRUS TYPE 4 A |
| 2024-08-22 | Department of Defense | $1.1M | 8510839749!ADENOVIRUS TYPE 4 A |
| 2024-03-13 | Department of Defense | $1.1M | 8510500489!ADENOVIRUS TYPE 4 A |
| 2022-12-06 | Department of Defense | $1.0M | 8509567884!ADENOVIRUS TYPE 4 A |
| 2022-12-06 | Department of Defense | $1.0M | 8509568637!ADENOVIRUS TYPE 4 A |